SCHEMBL2728683

SCHEMBL2728683

CCCCCCCCCCCCCC(=O)OP(=O)(OC(=O)CCCCCCCCCCCCC)C(O)C(O)CO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
MAPT P10636 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KDM4E B2RXH2 1/20 0.50
DUSP3 P51452 1/20 0.50
MAPK1 P28482 1/20 0.50
ENPP2 Q13822 2/20 0.44
LPAR6 P43657 1/20 0.44
LPAR1 Q92633 1/20 0.44
LPAR4 Q99677 1/20 0.44
LPAR5 Q9H1C0 1/20 0.44
LPAR2 Q9HBW0 1/20 0.44
LPAR3 Q9UBY5 1/20 0.44
PRKCA P17252 3/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCD Q05655 1/20 0.44
DGKA P23743 2/20 0.43
TRPV1 Q8NER1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4282445 1.00 LMNA (0.50) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL10275408 0.92 DGKA (0.56) MAPTENPP2LPAR6LPAR1LPAR4
SCHEMBL8087624 0.79 MAPK1 (0.49) LMNAMAPTMEN1KMT2AKDM4E
Glycerin SCHEMBL2718540 0.76 KDM4E (0.59) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL2782421 0.76 MAPT (0.46) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL25870 0.76 MAPT (0.46) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL2783097 0.76 MAPT (0.46) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL19019979 0.76 MEN1 (0.43) LMNAMAPTMEN1KMT2AKDM4E
SCHEMBL669205 0.74 DGKA (0.57) LMNAMAPTMEN1KMT2AMAPK1
SCHEMBL11026247 0.74 DGKA (0.57) LMNAMAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180311166-A1 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2018-11-01 US claimed
US-9808426-B2 Ternary mixture formulations WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2017-11-07 US claimed
US-20170128368-A1 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2017-05-11 US claimed
US-9492387-B2 Ternary mixture formulations WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2016-11-15 US claimed
US-20130310397-A1 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2013-11-21 US claimed
EP-2632437-A2 TERNARY MIXTURE FORMULATIONS Western University Of Health Sciences (US) 2013-09-04 EP claimed
WO-2012058668-A2 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2012-05-03 WO claimed
US-20180311166-A1 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2018-11-01 US disclosed
US-9808426-B2 Ternary mixture formulations WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2017-11-07 US disclosed
US-20170128368-A1 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2017-05-11 US disclosed
US-9492387-B2 Ternary mixture formulations WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2016-11-15 US disclosed
US-20130310397-A1 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2013-11-21 US disclosed
EP-2632437-A2 TERNARY MIXTURE FORMULATIONS Western University Of Health Sciences (US) 2013-09-04 EP disclosed
WO-2012058668-A2 TERNARY MIXTURE FORMULATIONS WESTERN UNIVERSITY OF HEALTH SCIENCES (US) 2012-05-03 WO disclosed
US-20040143093-A1 In vitro activation of configuration changes in recombinant proteins resulting in increased content of beta -sheet secondary structure (amyloidogenic aggregates) for use in modelin and treating nervous system, brain and autoimmune diseases EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) 2004-07-22 US disclosed
EP-1414854-A1 METHOD FOR INDUCING A CONFORMATIONAL TRANSITION IN PROTEINS SUCH AS PATHOGENIC/INFECTIOUS PROTEINS Eidgenoessische Technische Hochschule Zuerich (CH) 2004-05-06 EP disclosed
WO-2004007545-A1 METHOD FOR INDUCING A CONFORMATIONAL TRANSITION IN PROTEINS SUCH AS PATHOGENIC/INFECTIOUS PROTEINS EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (CH) 2004-01-22 WO disclosed